Venetoclax Elicits Immune Synapse Repair in Chronic Lymphocytic Leukemia
Envafolimab Plus Suvemcitug and FOLFIRI Shows Early Efficacy, Tolerability in Second-Line CRC
Emerging Data Continue to Shape the Role of Blinatumomab in Acute Lymphoblastic Leukemia
NX-5948 Demonstrates Preliminary Efficacy in High-Risk CLL